Sartorius AG
An international partner for the biopharmaceutical industry and life science research.
SRT3 | F
Overview
Corporate Details
- ISIN(s):
- DE0007165607 (+3 more)
- LEI:
- 529900EQV2DY4FOAMU38
- Country:
- Germany
- Address:
- Weender Landstraße 94-108, 37075 Göttingen
- Website:
- https://www.sartorius.com/en
- Sector:
- Manufacturing
- Industry:
- Manufacture of special-purpose machinery
Description
Sartorius is a leading international partner for the biopharmaceutical industry and life science research. The company provides a comprehensive portfolio of products and services that support the entire drug development and manufacturing process, from initial discovery to production. Key offerings include advanced solutions for filtration, fermentation, fluid management, cell analysis, and process analytics. The laboratory products division supplies essential equipment such as balances, pipettes, and water purification systems. Sartorius focuses on simplifying complex scientific processes to help customers translate discoveries into effective medicines more quickly and efficiently.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-02-13 00:00 |
Hinweis auf Konzernabschluss vom 01.01.2023 bis zum 31.12.2023
|
German | 5.8 KB | ||
| 2024-02-09 15:45 |
The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per pr…
|
English | 14.9 KB | ||
| 2024-02-07 00:39 |
SARTORIUS AG: Sartorius successfully completes placement of 200 million euros o…
|
English | 15.2 KB | ||
| 2024-02-06 18:13 |
SARTORIUS AG: Sartorius launches placement of up to 200 million euros of treasu…
|
English | 16.2 KB | ||
| 2024-01-26 07:00 |
Sartorius expects profitable growth in 2024; double-digit annual sales revenue …
|
English | 147.9 KB | ||
| 2024-01-02 15:29 |
Sartorius AG: Dr. Rene Faber, Transfer of 1525 preference shares as a share-bas…
|
English | 7.4 KB | ||
| 2024-01-02 15:21 |
Sartorius AG: Dr. Rene Faber, Transfer of 1923 ordinary shares as a share-based…
|
English | 7.4 KB | ||
| 2024-01-02 15:15 |
Sartorius AG: Dr. Alexandra Gatzemeyer, Transfer of 1186 preference shares as a…
|
English | 7.4 KB | ||
| 2024-01-02 15:09 |
Sartorius AG: Dr. Alexandra Gatzemeyer, Transfer of 1496 ordinary shares as a s…
|
English | 7.4 KB | ||
| 2023-12-11 16:14 |
Sartorius AG: Dr. Rene Faber, Grant of 1525 preference shares as a share-based …
|
English | 7.4 KB | ||
| 2023-12-11 16:00 |
Sartorius AG: Dr. Alexandra Gatzemeyer, Grant of 1496 ordinary shares as a shar…
|
English | 7.4 KB | ||
| 2023-10-19 07:00 |
SARTORIUS AG: Sartorius nine-month figures: Normalization of demand continues a…
|
English | 128.1 KB | ||
| 2023-10-12 21:05 |
SARTORIUS AG: Sartorius pre-announces preliminary 9-month results and lowers fo…
|
English | 20.2 KB | ||
| 2023-10-12 21:03 |
SARTORIUS AG: Sartorius pre-announces preliminary 9-month results and lowers fo…
|
English | 12.2 KB | ||
| 2023-10-12 15:00 |
SARTORIUS AG: Sartorius commits to climate neutrality by 2045 (news with addit…
|
English | 11.3 KB |
Automate Your Workflow. Get a real-time feed of all Sartorius AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sartorius AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sartorius AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-23 | Kappich, Dr. Lothar Ewald | Supervisory board | Buy | None | 41,840.00 EUR |
| 2022-11-15 | Kreuzburg, Dr. Joachim | Board | Sell | None | 8,000,000.00 EUR |
Peer Companies
